Butylamine

Butylamine

SCHEMBL627676

CCCC[NH3+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.39
TSHR P16473 1/20 0.36
LTA4H P09960 2/20 0.35
PCSK9 Q8NBP7 1/20 0.35
PTGS2 P35354 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
HSD11B1 P28845 1/20 0.33
GPR84 Q9NQS5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetradecylamine SCHEMBL9479923 0.92 DNM1 (0.52) DNM1LTA4HSMN1; SMN2SIGMAR1CES2
Octadecylamine SCHEMBL23038595 0.92 DNM1 (0.52) DNM1LTA4HSMN1; SMN2SIGMAR1CES2
Hexadecylamine SCHEMBL7631681 0.92 DNM1 (0.52) DNM1LTA4HSMN1; SMN2SIGMAR1CES2
Propylamine SCHEMBL3388064 0.89 TP53 (0.36) TSHRLTA4HPCSK9SMN1; SMN2ALDH1A1
Phenylboronic Acid SCHEMBL27868450 0.86 PCSK9 (0.46) PCSK9ALDH1A1LMNANPSR1HSD17B10
Octane SCHEMBL18395350 0.84 DNM1 (0.44) DNM1TSHRLTA4HSMN1; SMN2SIGMAR1
Ethylamine SCHEMBL2230804 0.84 TP53 (0.39) TSHRSMN1; SMN2ALDH1A1LMNANPSR1
SCHEMBL10434550 0.82 LTA4H (0.39) DNM1TSHRLTA4HPCSK9SMN1; SMN2
Octane SCHEMBL23754774 0.82 DNM1 (0.42) DNM1LTA4HSMN1; SMN2ALDH1A1SIGMAR1
Butylamine SCHEMBL2797837 0.82 DNM1 (0.34) DNM1TSHRLTA4HPCSK9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113614123-B Transition metal bis (phenoxide) complexes and their use as olefin polymerization catalysts 埃克森美孚化学专利公司 2024-01-23 CN claimed
CN-116490528-A Polymer compositions containing cyclics obtained using transition metal bis (phenoxide) catalyst complexes and process for their preparation 埃克森美孚化学专利公司 2023-07-25 CN claimed
CN-116323694-A Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof 埃克森美孚化学专利公司 2023-06-23 CN claimed
CN-113423744-B Lewis base catalyst and method thereof 埃克森美孚化学专利公司 2023-05-05 CN claimed
CN-113423742-B Bis (arylphenoxide) lewis base catalysts and methods thereof 埃克森美孚化学专利公司 2023-05-05 CN claimed
CN-115362187-A Polyethylene compositions obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-18 CN claimed
CN-115315455-A Ethylene-alpha-olefin-diene monomer copolymers obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-08 CN claimed
CN-115315452-A Propylene polymers obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-08 CN claimed
CN-114867758-A Metallocenes and methods thereof 埃克森美孚化学专利公司 2022-08-05 CN claimed
CN-113874401-A Metallocenes containing two-SI-SI-bridges 埃克森美孚化学专利公司 2021-12-31 CN claimed
CN-1240796-A Ethylene polymers with alpha-olefins SIAC IT ADDITIVI CARBURANTI (IT) 2000-01-12 CN claimed
EP-0832136-A4 POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION QUANTUM CHEM CORP (US) 1998-09-30 EP claimed
CN-1186813-A Ethylene/alpha-olefins copolymers ITLIANA ADDITIVI PER CARBURANT (IT) 1998-07-08 CN claimed
EP-0832136-A1 POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION QUANTUM CHEMICAL CORPORATION (US) 1998-04-01 EP claimed
WO-1996035726-A1 POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION QUANTUM CHEMICAL CORPORATION (US) 1996-11-14 WO claimed
EP-4046984-B1 COMPOUND, RESIN, POLYCARBONATE RESIN, AND OPTICAL MOLDED BODY MITSUI CHEMICALS INC (JP) 2025-09-03 EP disclosed
US-12240945-B2 Compound, resin, polycarbonate resin, and optical molded article MITSUI CHEMICALS, INC. (JP) 2025-03-04 US disclosed
EP-0417514-A2 Method for preparing reactively terminated polycarbonates GENERAL ELECTRIC COMPANY (US) 1991-03-20 EP disclosed
EP-0198338-B1 METHOD FOR PREPARING LINEAR POLYCARBONATES FROM CYCLIC OLIGOMERS GENERAL ELECTRIC COMPANY (US) 1989-07-05 EP disclosed
EP-0267369-A2 Method for converting cyclic polycarbonate oligomer mixtures to linear polycarbonates, and compositions resulting therefrom GENERAL ELECTRIC COMPANY (US) 1988-05-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240945-B2 Compound, resin, polycarbonate resin, and optical molded article ARL1, RER1, SEM1 DNM1 857/4885TSHR 4317/4885LTA4H 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.